Status:
ACTIVE_NOT_RECRUITING
Safety and Efficacy of EUS-RFA in the Treatment of Pancreatic Lesions: A Prospective Registry
Lead Sponsor:
The University of Texas Health Science Center, Houston
Conditions:
Pancreatic Cyst
Eligibility:
All Genders
18+ years
Brief Summary
Purpose: The purpose of this registry is to track the clinical outcomes and progression of patients with pancreatic lesions receiving endoscopic ultrasound (EUS)-based radiofrequency ablation (RFA) th...
Eligibility Criteria
Inclusion
- 1\. Diagnosis of any pancreatic premalignant lesion and/or pancreatic malignancy
Exclusion
- Patients with co-existing malignancies of other organs (or a prior history of such)
- Patients unable to provide informed consent
- Patients unable to complete follow-up
Key Trial Info
Start Date :
October 30 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2028
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT07136324
Start Date
October 30 2018
End Date
July 1 2028
Last Update
August 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Hermann Hospital
Houston, Texas, United States, 77054